Hôpital Estaing - CHU de Clermont-Ferrand
- Address
- 1 Rue Lucie et Raymond Aubrac, 63003 Clermont-Ferrand, France
Hôpital Estaing - CHU de Clermont-Ferrand
Hôpital Estaing, part of the CHU de Clermont-Ferrand, is a leading academic medical center conducting advanced clinical research across multiple therapeutic areas. The center demonstrates particular expertise in oncology, hepatobiliary disorders, autoimmune conditions, and precision medicine approaches guided by genomic biomarkers.
- Hepatobiliary diseases including primary biliary cholangitis with novel combination therapies
- Oncology studies spanning primary CNS lymphoma, pancreatic ductal adenocarcinoma, colorectal cancer, and targeted therapies for BRAF-mutated tumors
- Autoimmune and inflammatory conditions such as granulomatosis with polyangiitis
- Immunotherapy combinations and precision medicine trials utilizing molecular profiling
The research center participates in innovative trials evaluating immunotherapy combinations including checkpoint inhibitors, targeted molecular therapies for specific genomic alterations, and salvage treatment strategies for patients with inadequate response to standard therapies. Their portfolio reflects a commitment to personalized medicine, focusing on biomarker-driven patient selection including HLA typing, microsatellite instability status, and BRAF mutation analysis to optimize treatment outcomes across diverse malignancies and complex autoimmune disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 of 3 therapeutic areas and 15 of 23 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hôpital Estaing - CHU de Clermont-Ferrand
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Bezafibrate 400 mg and 200 mg as Adjunctive Therapy in Primary Biliary Cholangitis with Suboptimal Ursodeoxycholic Acid Response: A Randomized, Double-Blind, Placebo-Controlled Trial | Assistance Publique Hopitaux De Paris | Phase III | Recruiting | Mar 2025 | — |
IMP list
lock Showing 1 of 23 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Azathioprine | 1 | Unknown | 2025-06-06 | 2025-06-06 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.